HighTower Advisors »

Aprea Therapeutics shares owned by HighTower Advisors

Quarter-by-quarter ownership of Aprea Therapeutics (APRE) shares owned by HighTower Advisors from 13F filings

Historical chart of HighTower Advisors investment in Aprea Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aprea Therapeutics held by HighTower Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aprea Therapeutics by HighTower Advisors

Quarter filed Position value Share count Share price at filing
2024-06-30 $56k 14k 4.04
2024-03-31 $93k 14k 6.71

More positions owned by HighTower Advisors

Apple (AAPL)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Amazon (AMZN)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Exxon Mobil Corporation (XOM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Johnson & Johnson (JNJ)

View all positions for HighTower Advisors

Top funds holding Aprea Therapeutics

AIGH Capital Management
Sio Capital Management
Sphera Funds Management
Nantahala Capital Management
Altium Capital Management
DAFNA Capital Management
Exome Asset Management
Stonepine Capital Management
Vanguard Group
Geode Capital Management
Morgan Stanley
Dimensional Fund Advisors
HighTower Advisors
Susquehanna International
BlackRock

View all funds holding Aprea Therapeutics